Nanotechnology

Using a new technology, future clinicians may be able to more accurately diagnose and appropriately treat ectopic pregnancies than they would with traditional methods, according to data published in Small.

One of the major challenges in the field of nanomedicine is translating in vitro performance of nanoparticles to in vivo studies, a factor that may hinder the development of nanoparticles as drug delivery vehicles.

Nanomedicine has been a promising area of clinical research — particularly in the cancer setting — for decades, and experts said its potential has only increased with advances in cancer diagnostics and therapeutics.

In a research collaboration with Mayo Clinic, nanomedical company NaNotics LLC plans to develop and assess a novel subtractive nanoparticle for use in cancer treatment.

Cato T. Laurencin MD, PhD, has received the 2020 Von Hippel Award, the highest honor of the Materials Research Society, according to a press release.